These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38070662)

  • 1. Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection.
    Liao T; Shi X; Han F; Wang Y; Zeng W; Liu R; Yan Z; Xia R; Huang Z; Xu J; Miao Y
    J Heart Lung Transplant; 2024 Apr; 43(4):652-662. PubMed ID: 38070662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model.
    Bath NM; Ding X; Verhoven BM; Wilson NA; Coons L; Sukhwal A; Zhong W; Redfield Iii RR
    PLoS One; 2019; 14(10):e0223889. PubMed ID: 31647850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.
    Wilson NA; Bath NM; Verhoven BM; Ding X; Boldt BA; Sukhwal A; Zhong W; Panzer SE; Redfield RR
    Transplantation; 2019 Jul; 103(7):1372-1384. PubMed ID: 30830041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.
    Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H
    Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase ablation inhibits B cell responses and antibody production for the prevention of chronic rejection in cardiac transplantation.
    Han F; Shi X; Liao T; Zhang W; Ma M; Leng Q; Jiang W; Na N; Miao Y; Huang Z
    Clin Immunol; 2024 Apr; 261():109941. PubMed ID: 38365047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.
    Bath NM; Ding X; Wilson NA; Verhoven BM; Boldt BA; Sukhwal A; Reese SR; Panzer SE; Djamali A; Redfield RR
    PLoS One; 2019; 14(2):e0211865. PubMed ID: 30735519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model.
    Bath NM; Verhoven BM; Wilson NA; Zeng W; Zhong W; Coons L; Djamali A; Redfield RR
    PLoS One; 2022; 17(10):e0275564. PubMed ID: 36227902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease.
    Shi F; Xue R; Zhou X; Shen P; Wang S; Yang Y
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):666-673. PubMed ID: 34519594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection.
    Wang G; Zou D; Wang Y; Gonzalez NM; Yi SG; Li XC; Chen W; Gaber AO
    J Heart Lung Transplant; 2021 Oct; 40(10):1122-1132. PubMed ID: 34253454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
    Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.
    Parsons RF; Vivek K; Redfield RR; Migone TS; Cancro MP; Naji A; Noorchashm H
    Transplant Rev (Orlando); 2010 Oct; 24(4):207-21. PubMed ID: 20655723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
    Halpern WG; Lappin P; Zanardi T; Cai W; Corcoran M; Zhong J; Baker KP
    Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Activation-induced Cytidine Deaminase, a Regulator of Class Switch Recombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice.
    Nakanishi T; Xu X; Wynn C; Yamada T; Pan F; Erickson L; Teo H; Nakagawa T; Masunaga T; Abe J; Akamatsu M; Tamura K; Jiang H
    Transplantation; 2015 Aug; 99(8):1598-605. PubMed ID: 25769064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitization.
    Agarwal D; Luning Prak ET; Bharani T; Everly M; Migone TS; Cancro M; Allman D; Choe I; Kearns JD; Trofe-Clark J; Naji A; Kamoun M
    Transpl Immunol; 2021 Dec; 69():101465. PubMed ID: 34506905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection.
    Young JS; Chen J; Miller ML; Vu V; Tian C; Moon JJ; Alegre ML; Sciammas R; Chong AS
    Am J Transplant; 2016 Aug; 16(8):2312-23. PubMed ID: 26928966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases.
    Zeng L; Yang K; Wu Y; Yu G; Yan Y; Hao M; Song T; Li Y; Chen J; Sun L
    J Autoimmun; 2024 Sep; 148():103291. PubMed ID: 39146891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
    Spinelli FR; Barbati C; Cecarelli F; Morello F; Colasanti T; Vomero M; Massaro L; Orefice V; Alessandri C; Valesini G; Conti F
    Arthritis Res Ther; 2019 Nov; 21(1):245. PubMed ID: 31752963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.